Isavuconazonium
- Generic Name
- Isavuconazonium
- Brand Names
- Cresemba
- Drug Type
- Small Molecule
- Chemical Formula
- C35H35F2N8O5S
- CAS Number
- 742049-41-8
- Unique Ingredient Identifier
- VH2L779W8Q
- Background
Isavuconazonium is a second-generation triazole antifungal approved on March 6, 2015 by the FDA for the treatment of invasive aspergillosis and invasive mucormycosis, marketed by Astellas under the brand Cresemba. It is the prodrug form of isavuconazole, the active moiety, and it is available in oral and parenteral formulations. Due to low solubility in wate...
- Indication
Indicated in the treatment of invasive aspergillosis and invasive mucormycosis.
- Associated Conditions
- Disseminated mucormycosis, Invasive Aspergillosis
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath